Skip to main content
. 2012 Feb 15;8(1):67–75. doi: 10.5664/jcsm.1666

Table 2.

Sleep characteristics and symptom experience by sleep quantity

Variable Short Sleep (< 6 h) (n = 131) Typical Sleep (6 – 7.9 h) (n = 121) Long Sleep (≥ 8 h) (n = 38) Statisticsa (when p < 0.20)
    Demographic
        Race χ2(4) = 24.9, p < 0.001
            African American 66 (50%)** 37 (30%)* 8 (21%)*
            Caucasian 34 (26%)** 60 (50%)* 24 (63%)*
            Other 31 (24%) 24 (20%) 6 (16%)
        Education χ2(2) = 11.1, p = 0.004
            High school or less 113 (86%)* 90 (74%) 24 (63%)*
            More than high school 18 (14%)* 31 (26%) 14 (37%)*
        Household Income χ2(2) = 9.16, p = 0.010
            < $1,000/month 102 (78%)* 76 (63%) 22 (58%)*
            $1,000/month or more 29 (22%)* 45 (37%) 16 (42%)*
    Clinical
        CD4+ T-cell count (cells/mm3)b 398 ± 256* 502 ± 273* 470 ± 259 F2,273 = 4.62, p = 0.011
        Viral Load (log10 copies/mL)b 2.09 ± 1.99 1.56 ± 1.89 1.61 ± 2.00 F2,267 = 2.29, p = 0.103
    Perceived Sleep Disturbance
        PSQI Global score 7.7 ± 3.8 7.3 ± 3.7 7.2 ± 3.3 ns
    Actigraphy
        Time in bed (minutes) 452 ± 78** 511 ± 59** 593 ± 70** F2,287 = 65.6, p < 0.001
        Total sleep time (minutes) 284 ± 58** 416 ± 34** 526 ± 46** F2,287 = 473, p < 0.001
        Sleep efficiency (% of TIB) 63.9 ± 14.6** 82.1 ± 9.1** 89.0 ± 6.02** F2,287 = 110, p < 0.001
        Wake after sleep onset (%)b 30.6 ± 14.9** 14.2 ± 8.7** 8.5 ± 6.1** F2,287 = 91.1, p < 0.001
        Day sleep (minutes)b 44 ± 51* 58 ± 57 86 ± 80* F2,280 = 6.8, p = 0.001
    Symptom Experience
        Number of symptoms (MSAS) 9.5 ± 5.8 8.2 ± 5.7 10.8 ± 6.6 F2,277 = 3.2, p = 0.043
        Depression (CES-D)b 16.0 ± 10.2* 16.3 ± 10.7* 21.2 ± 11.3** F2,285 = 3.1, p = 0.023
        Anxiety (POMS subscale)b 8.3 ± 7.0 8.7 ± 6.9 10.3 ± 7.7 ns
        Fatigue (sleep diary)
            Morning 3.4 ± 2.3 3.7 ± 2.3 3.7 ± 2.1 ns
            Evening 5.3 ± 2.3 5.1 ± 2.2 5.5 ± 2.1 ns
            Evening-Morning difference 1.9 ± 1.9 1.5 ± 1.9 1.7 ± 1.8 ns
a

Analyses for comparing the 3 groups included χ2 for demographic variables and an omnibus ANOVA and Scheffe post hoc tests for continuous variables.

b

Square root transformation used to normalize distribution.

*

Post hoc testing indicates this group significantly differs (p ≤ 0.005) from one of the other groups.

**

Post hoc testing indicates this group significantly differs (p ≤ 0.005) from both of the other groups.